Non-adherence to oral antidiabetic medications among patients with type 2 diabetes: evidence from a nationwide multicenter study in a lower-middle-income country

Published in Public Health

Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Non-adherence to oral antidiabetic medications among patients with type 2 diabetes: evidence from a nationwide multicentre study in a lower-middle-income country - BMC Public Health

Background Non-adherence to oral antidiabetic medications is a critical, multifactorial challenge that undermines disease management nationwide. This study aimed to determine the prevalence and predictors of non-adherence among patients with type 2 diabetes (T2DM) across Pakistan. We conducted a nationwide cross-sectional study between December 2023 and March 2025 in 225 healthcare facilities across all provinces of Pakistan. A total of 41,095 participants were selected using a multistage random sampling approach. Medication adherence was evaluated with self-reported pill counts and the Self-Efficacy for Appropriate Medication Use Scale (SEAMS). Multivariable logistic regression using a generalized linear model (GLM) logit approach was employed integrated with Interaction analysis to discover predictors of non-adherence. Result Non-adherence was present in 59.9% (n=24,616) of cases (n=24,616). Factors associated with reduced adherence included being female (AOR = 0.229, 95% CI: 0.067–0.779, P = 0.02), having only primary or secondary education (AOR = 0.186, 95% CI: 0.166–0.208, P < 0.001), absence of hospitalization, taking fewer medications per day, less frequent dosing schedules, and uncontrolled HbA1c levels. In contrast, factors linked to increased adherence were being married (AOR = 4.118, 95% CI: 3.611–4.695, P < 0.001), being a non-smoker (AOR = 12.98, 95% CI: 11.53–14.62, P < 0.001), having no family history of diabetes (AOR = 1.074, 95% CI: 1.021–1.129, P = 0.005), and having more than one comorbid condition. Conclusion Non-adherence to oral antidiabetic medication is prevalent and influenced by diverse personal, socioeconomic, and health-related factors. Targeted interventions addressing modifiable risk factors could improve adherence, ultimately reduce the healthcare burden and enhancing outcomes for patients with diabetes in Pakistan.

We're excited to share our team's recent efforts, which concluded a nationwide study in Pakistan assessing medication adherence among over 41,000 Type 2 Diabetes patients. The results, now published in BMC Public Health, are a wake-up call:

nearly 60% of patients are not adhering to their oral antidiabetic medications.

This isn't just a medical issue; it's a socioeconomic one. Our data shows that financial constraints, education levels, and even language barriers play a critical role.

What’s the solution? We cannot rely on "education-only" strategies. Our study suggests we need:

✅ Simplified dosing regimens.

✅ Targeted mHealth interventions (SMS reminders).

✅ Stronger peer-support networks in primary care.

We hope these findings will help shape smarter public health policies for chronic disease management in Pakistan. Because it’s not enough to prescribe medication, we must ensure patients can take it.

Full Paper: https://rdcu.be/eQYXf

#HealthPolicy #GlobalHealth #DiabetesAwareness #HealthcareInnovation #ResearchImpact

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Public Health
Life Sciences > Health Sciences > Public Health

Related Collections

With Collections, you can get published faster and increase your visibility.

Monitoring, preventing, and managing type 2 diabetes

BMC Public Health is calling for submissions to our Collection on Monitoring, preventing, and managing diabetes at the population level. With rates of type 2 diabetes rising globally, especially in low- and middle-income countries and underserved communities, prevention strategies are critical. As the disease progresses people with diabetes are at increased risk of complications such as cardiovascular and kidney diseases, neuropathy and visual loss.

This Collection seeks submissions that explore population-level approaches to monitoring rates of diabetes, preventing or delaying the development of type 2 diabetes, and system-wide efforts to improve the management of the disease and reduce rates of complications, with a focus on improving health outcomes and reducing healthcare burdens.

Submissions are encouraged on primary prevention initiatives and culturally adapted, community-level interventions to reduce the risk of diabetes. Research aimed at improving systems for monitoring rates of diabetes and its complications through routinely-collected health data, or for improving management by enhancing patient engagement with healthcare systems or better identifying those in need, are encouraged. Research on diabetes education and support systems is also welcomed, with a focus on empowering individuals to adopt and sustain healthier lifestyles and avoid known causes of diabetes.

Additional topics of interest include (but are not limited to):

Access to healthcare and diabetes management

The impact of food insecurity on diabetes outcomes

Community-based interventions for low-income populations

Interventions to reduce exposure to environmental causes of diabetes

Financial barriers to diabetes medication and treatment

Housing instability, employment status and type 2 diabetes

Health literacy, poverty, and diabetes management

Policies to reduce poverty-related health disparities in diabetes

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Jul 16, 2026

Endocrine disruption as a public health issue

BMC Public Health invites submissions to our new Collection, Endocrine disruption as a public health issue. Endocrine disruption has emerged as a growing public health challenge, characterized by the interference of certain chemicals with the normal functioning of the endocrine system. Endocrine disrupting chemicals (EDCs) can mimic, block, or alter hormone signaling, leading to a range of adverse health outcomes. Common sources of EDC exposure include everyday products such as plastics, pesticides, and personal care items, all of which can release substances like bisphenols and phthalates into the environment and human body. Understanding the links between exposure to EDCs and eventual health outcomes is vital for assessing their implications for population health.

We welcome submissions that delve into various aspects of endocrine disruption. Key topics of interest include, but are not limited to:

Role of EDCs in metabolic, endocrine and immune-related disorders

Effect of EDCs in consumer products including personal care products

The links between EDC exposure and male and female reproductive health problems

The links between EDC exposure and certain cancers

Insights into the long-term consequences of early-life EDC exposure and transgenerational effects

Methodological advances in assessing the health impacts of EDC mixtures and cumulative exposures

Development and application of statistical approaches to better estimate the health effects of chronic and/or concurrent exposure

Validating models of cumulative exposure with measurement of combinations of EDCs in human tissues

Individual- and policy-level interventions to address health impacts of EDC exposures

The search for substitutes lacking endocrine disrupting properties

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Aug 26, 2026